Clinical Trial

Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Name: Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) — clinical trial record (NCT07701967)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study will evaluate the efficacy and safety of depemokimab (GSK3511294) without concomitant use of Intranasal corticosteroids (INCS) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).

Trial Details

NCT Number	NCT07701967
Lead Sponsor	GlaxoSmithKline
Conditions	Nasal Polyps
Enrollment	28 participants
Start Date	2026-07-20
Primary Completion	2027-07-01 (estimated)
Study Completion	2028-06-16 (estimated)
Updated on ClinicalTrials.gov	2026-07-14